A Healthy Biotech ETF

To put it delicately, 2014 has been an interesting and volatile year for biotechnology stocks and the exchange traded funds that hold those shares. Biotech stocks usually trade at a hefty premium to the broader U.S. market, but earlier this year as the industry’s valuations became noticeably...